Moderna
$153.309876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$153.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$6.43 (+4.33%) Today
-$1.51 (-0.98%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Moderna and other stocks, options, and ETFs commission-free!
About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA. The listed name for MRNA is Moderna, Inc. Common Stock.
CEO
Stéphane Bancel
Employees
830
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
63.54B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.48M
High Today
$159.60
Low Today
$150.88
Open Price
$157.98
Volume
13.45M
52 Week High
$189.26
52 Week Low
$19.31
MRNA News
MarketWatch7h
Moderna Inc. stock outperforms market on strong trading day
Shares of Moderna Inc. MRNA, +4.33% rose 4.33% to $154.81 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ
Analyst Ratings
50%
of 16 ratings
Buy
50%
Hold
31%
Sell
19%
MRNA Earnings
-$0.69
-$0.46
-$0.23
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
-$0.69 per share
